Invenomic Capital Management’s Cass Information Systems CASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-56,535
Closed -$2.19M 150
2023
Q2
$2.19M Buy
+56,535
New +$2.22M 0.11% 111
2022
Q3
Sell
-40,906
Closed -$1.38M 153
2022
Q2
$1.38M Buy
40,906
+212
+0.5% +$7.61K 0.1% 127
2022
Q1
$1.22M Buy
40,694
+3,175
+8% +$127K 0.13% 129
2021
Q4
$1.48M Sell
37,519
-14,772
-28% -$626K 0.32% 90
2021
Q3
$2.19M Buy
52,291
+50,162
+2,356% +$2.14M 0.71% 47
2021
Q2
$87K Buy
+2,129
New +$95.8K 0.02% 117

Other funds holding CASS

Invenomic Capital Management's CASS Position: Q3 2023 in Review

Invenomic Capital Management sold out of Cass Information Systems (CASS) in Q3 2023, closing a stake of 56,535 shares — an estimated $2.19M sold.

Invenomic Capital Management first reported a position in CASS in Q2 2021 and held it in 6 quarters. The position peaked at $2.19M in Q2 2023. 125 funds tracked by Wall St. Rank hold CASS as of Q3 2023.

  • Invenomic Capital Management reported no remaining Cass Information Systems position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 56,535 Cass Information Systems shares in Q3 2023, an estimated $2.19M.
  • Invenomic Capital Management first reported a position in Cass Information Systems in Q2 2021 and held it in 6 quarters.
  • Invenomic Capital Management's Cass Information Systems position peaked at $2.19M in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Cass Information Systems as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.